Zeidan, A., Zhuoxin, S., Prebet, T., Greenberg, P., Juckett, M., Smith, M., … Tallman, M. (2013). P-124 Application of the French Prognostic Score to assess overall survival in a US-based cohort of patients treated with azacitidine. In Leukemia Research (Vol. 37, pp. S79–S80). Elsevier BV. https://doi.org/10.1016/s0145-2126(13)70172-3

Zeidan, A., S. Zhuoxin, T. Prebet, P. Greenberg, M. Juckett, M. Smith, E. Paietta, et al. “P-124 Application of the French Prognostic Score to assess overall survival in a US-based cohort of patients treated with azacitidine.” In Leukemia Research, 37:S79–80. Elsevier BV, 2013. https://doi.org/10.1016/s0145-2126(13)70172-3.

Zeidan A, Zhuoxin S, Prebet T, Greenberg P, Juckett M, Smith M, et al. P-124 Application of the French Prognostic Score to assess overall survival in a US-based cohort of patients treated with azacitidine. In: Leukemia Research. Elsevier BV; 2013. p. S79–80.

Zeidan, A., et al. “P-124 Application of the French Prognostic Score to assess overall survival in a US-based cohort of patients treated with azacitidine.” Leukemia Research, vol. 37, Elsevier BV, 2013, pp. S79–80. Crossref, doi:10.1016/s0145-2126(13)70172-3.

Zeidan A, Zhuoxin S, Prebet T, Greenberg P, Juckett M, Smith M, Paietta E, Gabrilove J, Erba H, Gore S, Tallman M. P-124 Application of the French Prognostic Score to assess overall survival in a US-based cohort of patients treated with azacitidine. Leukemia Research. Elsevier BV; 2013. p. S79–S80.